Literature DB >> 17273171

Regulatory T cell development in the absence of functional Foxp3.

Wen Lin1, Dipica Haribhai, Lance M Relland, Nga Truong, Marc R Carlson, Calvin B Williams, Talal A Chatila.   

Abstract

Although the development of regulatory T cells (T(reg) cells) in the thymus is defined by expression of the lineage marker Foxp3, the precise function of Foxp3 in T(reg) cell lineage commitment is unknown. Here we examined T(reg) cell development and function in mice with a Foxp3 allele that directs expression of a nonfunctional fusion protein of Foxp3 and enhanced green fluorescent protein (Foxp3DeltaEGFP). Thymocyte development in Foxp3DeltaEGFP male mice and Foxp3DeltaEGFP/+ female mice recapitulated that of wild-type mice. Although mature EGFP(+) CD4(+) T cells from Foxp3DeltaEGFP mice lacked suppressor function, they maintained the characteristic T(reg) cell 'genetic signature' and failed to develop from EGFP(-) CD4(+) T cells when transferred into lymphopenic hosts, indicative of their common ontogeny with T(reg) cells. Our results indicate that T(reg) cell effector function but not lineage commitment requires the expression of functional Foxp3 protein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17273171     DOI: 10.1038/ni1445

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  216 in total

1.  The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota.

Authors:  June L Round; S Melanie Lee; Jennifer Li; Gloria Tran; Bana Jabri; Talal A Chatila; Sarkis K Mazmanian
Journal:  Science       Date:  2011-04-21       Impact factor: 47.728

2.  Mammalian target of rapamycin activation underlies HSC defects in autoimmune disease and inflammation in mice.

Authors:  Chong Chen; Yu Liu; Yang Liu; Pan Zheng
Journal:  J Clin Invest       Date:  2010-10-25       Impact factor: 14.808

Review 3.  The biology of FoxP3: a key player in immune suppression during infections, autoimmune diseases and cancer.

Authors:  Frances Mercer; Derya Unutmaz
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

4.  Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells.

Authors:  Weiming Ouyang; Omar Beckett; Qian Ma; Ji-hye Paik; Ronald A DePinho; Ming O Li
Journal:  Nat Immunol       Date:  2010-05-13       Impact factor: 25.606

Review 5.  Mechanisms of self-nonself discrimination and possible clinical relevance.

Authors:  Carolin Daniel; Jens Nolting; Harald von Boehmer
Journal:  Immunotherapy       Date:  2009-07       Impact factor: 4.196

6.  CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity.

Authors:  Amy J Beres; Dipica Haribhai; Alexandra C Chadwick; Patrick J Gonyo; Calvin B Williams; William R Drobyski
Journal:  J Immunol       Date:  2012-05-30       Impact factor: 5.422

7.  Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict.

Authors:  Robert M Samstein; Steven Z Josefowicz; Aaron Arvey; Piper M Treuting; Alexander Y Rudensky
Journal:  Cell       Date:  2012-07-06       Impact factor: 41.582

8.  Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients.

Authors:  Giorgio Raimondi; Tina L Sumpter; Benjamin M Matta; Mahesh Pillai; Natasha Corbitt; Yoram Vodovotz; Zhiliang Wang; Angus W Thomson
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

Review 9.  Breakdown of T cell tolerance and autoimmunity in primary immunodeficiency--lessons learned from monogenic disorders in mice and men.

Authors:  Lisa S Westerberg; Christoph Klein; Scott B Snapper
Journal:  Curr Opin Immunol       Date:  2008-11-12       Impact factor: 7.486

Review 10.  Restoring Regulatory T Cells in Type 1 Diabetes.

Authors:  Allyson Spence; Qizhi Tang
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.